- Report
- April 2023
- 200 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- April 2023
- 500 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Report
- April 2023
- 350 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Report
- October 2022
- 300 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- October 2022
- 100 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- February 2021
- 50 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Report
- February 2021
- 50 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Report
- March 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- March 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- January 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- January 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- May 2024
- 130 Pages
Global
From €5732EUR$6,499USD£4,962GBP
- Report
- May 2024
- 129 Pages
Global
From €5732EUR$6,499USD£4,962GBP
- Report
- May 2024
- 138 Pages
Global
From €5732EUR$6,499USD£4,962GBP
- Report
- July 2024
- 150 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- June 2024
- 200 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- February 2025
- 85 Pages
India
From €3087EUR$3,500USD£2,672GBP
- Report
- July 2024
- 185 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2024
- 184 Pages
Global
From €3969EUR$4,500USD£3,436GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more